{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:31:42Z","timestamp":1781652702423,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T00:00:00Z","timestamp":1485820800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Biomedical Image Quantification\/University Alliance of Finland"},{"name":"the Elna Savolainen Fund of Tampere University Hospital Research Center"},{"name":"The Seppo Nieminen Fund of Tampere University Hospital Research Center"},{"DOI":"10.13039\/501100004756","name":"The Emil Aaltonen Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004756","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11307-017-1044-3","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T08:50:18Z","timestamp":1485852618000},"page":"787-794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Association Between Liver and Tumor [18F]FDG Uptake in Patients with Diffuse Large B Cell Lymphoma During Chemotherapy"],"prefix":"10.1007","volume":"19","author":[{"given":"Xingchen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhisek","family":"Bhattarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Korkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Pertovaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Eskola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirkko-Liisa","family":"Kellokumpu-Lehtinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,31]]},"reference":[{"key":"1044_CR1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u2013586","journal-title":"J Clin Oncol"},{"key":"1044_CR2","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1200\/JCO.2010.32.5225","volume":"29","author":"BD Cheson","year":"2011","unstructured":"Cheson BD (2011) Role of functional imaging in the management of lymphoma. J Clin Oncol 29:1844\u20131854","journal-title":"J Clin Oncol"},{"key":"1044_CR3","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.ejca.2010.12.027","volume":"47","author":"DH Yang","year":"2011","unstructured":"Yang DH, Min JJ, Song HC et al (2011) Prognostic significance of interim (1)(8)F-FDG PET\/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma. Eur J Cancer 47:1312\u20131318","journal-title":"Eur J Cancer"},{"key":"1044_CR4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.110.082586","volume":"52","author":"AF Cashen","year":"2011","unstructured":"Cashen AF, Dehdashti F, Luo J et al (2011) 18F-FDG PET\/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation. J Nucl Med 52:386\u2013392","journal-title":"J Nucl Med"},{"key":"1044_CR5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1182\/blood-2005-01-0272","volume":"106","author":"C Haioun","year":"2005","unstructured":"Haioun C, Itti E, Rahmouni A et al (2005) [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 106:1376\u20131381","journal-title":"Blood"},{"key":"1044_CR6","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/annonc\/mdi272","volume":"16","author":"NG Mikhaeel","year":"2005","unstructured":"Mikhaeel NG, Hutchings M, Fields PA et al (2005) FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol 16:1514\u20131523","journal-title":"Ann Oncol"},{"key":"1044_CR7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00277-010-1135-6","volume":"90","author":"C Yoo","year":"2011","unstructured":"Yoo C, Lee DH, Kim JE et al (2011) Limited role of interim PET\/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP. Ann Hematol 90:797\u2013802","journal-title":"Ann Hematol"},{"key":"1044_CR8","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood-2011-06-359943","volume":"119","author":"P Pregno","year":"2012","unstructured":"Pregno P, Chiappella A, Bello M et al (2012) Interim 18FDG-PET\/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP. Blood 119:2066\u20132073","journal-title":"Blood"},{"key":"1044_CR9","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428190903040048","volume":"50","author":"M Meignan","year":"2009","unstructured":"Meignan M, Gallamini A, Meignan M et al (2009) Report on the first international workshop on interim-PET-scan in lymphoma. Leuk Lymphoma 50:1257\u20131260","journal-title":"Leuk Lymphoma"},{"key":"1044_CR10","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3109\/10428190903275610","volume":"50","author":"NG Mikhaeel","year":"2009","unstructured":"Mikhaeel NG (2009) Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now? Leuk Lymphoma 50:1931\u20131936","journal-title":"Leuk Lymphoma"},{"key":"1044_CR11","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00259-010-1490-5","volume":"37","author":"SF Barrington","year":"2010","unstructured":"Barrington SF, Qian W, Somer EJ et al (2010) Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 37:1824\u20131833","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1044_CR12","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3109\/10428194.2010.529208","volume":"51","author":"M Meignan","year":"2010","unstructured":"Meignan M, Gallamini A, Haioun C, Polliack A (2010) Report on the second international workshop on interim positron emission tomography in lymphoma held in Menton, France, 8\u20139 April 2010. Leuk Lymphoma 51:2171\u20132180","journal-title":"Leuk Lymphoma"},{"key":"1044_CR13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s11307-010-0404-z","volume":"13","author":"X Wu","year":"2011","unstructured":"Wu X, Dastidar P, Pertovaara H et al (2011) Early treatment response evaluation in patients with diffuse large B-cell lymphoma\u2014a pilot study comparing volumetric MRI and PET\/CT. Mol Imaging Biol 13:785\u2013792","journal-title":"Mol Imaging Biol"},{"key":"1044_CR14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/RLU.0b013e318263831d","volume":"37","author":"L Ceriani","year":"2012","unstructured":"Ceriani L, Suriano S, Ruberto T et al (2012) 18F-FDG uptake changes in liver and mediastinum during chemotherapy in patients with diffuse large B-cell lymphoma. Clin Nucl Med 37:949\u2013952","journal-title":"Clin Nucl Med"},{"key":"1044_CR15","first-page":"1123","volume":"41","author":"A Chiaravalloti","year":"2014","unstructured":"Chiaravalloti A, Danieli R, Abbatiello P et al (2014) Factors affecting intrapatient liver and mediastinal blood pool 18F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin\u2019s lymphoma. Eur J Nucl Med Mol Imaging 41:1123\u20131132","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1044_CR16","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s00330-009-1333-6","volume":"19","author":"PJ Robinson","year":"2009","unstructured":"Robinson PJ (2009) The effects of cancer chemotherapy on liver imaging. Eur Radiol 19:1752\u20131762","journal-title":"Eur Radiol"},{"key":"1044_CR17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00259-014-2926-0","volume":"42","author":"A Chiaravalloti","year":"2015","unstructured":"Chiaravalloti A, Schillaci O (2015) Reply to comments by Laffon et al.: Liver SUV versus stage in Hodgkin\u2019s lymphoma: the total amount of uptake may play a role in the inverse relationship. Eur J Nucl Med Mol Imaging 42:166","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"1044_CR18","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.2967\/jnumed.108.057182","volume":"50","author":"R Boellaard","year":"2009","unstructured":"Boellaard R (2009) Standards for PET image acquisition and quantitative data analysis. J Nucl Med 50(Suppl 1):11S\u201320S","journal-title":"J Nucl Med"},{"key":"1044_CR19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.nucmedbio.2014.06.003","volume":"41","author":"E Laffon","year":"2014","unstructured":"Laffon E, de Clermont H, Lamare F, Marthan R (2014) Estimating the amount of FDG uptake in physiological tissues. Nucl Med Biol 41:717\u2013720","journal-title":"Nucl Med Biol"},{"key":"1044_CR20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2967\/jnumed.112.108530","volume":"54","author":"RR Boktor","year":"2013","unstructured":"Boktor RR, Walker G, Stacey R et al (2013) Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET. J Nucl Med 54:677\u2013682","journal-title":"J Nucl Med"},{"key":"1044_CR21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/RLU.0b013e3182872f0e","volume":"38","author":"D Groheux","year":"2013","unstructured":"Groheux D, Delord M, Rubello D et al (2013) Variation of liver SUV on 18FDG-PET\/CT studies in women with breast cancer. Clin Nucl Med 38:422\u2013425","journal-title":"Clin Nucl Med"},{"key":"1044_CR22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1078155206072982","volume":"12","author":"CD Duong","year":"2006","unstructured":"Duong CD, Loh JY (2006) Laboratory monitoring in oncology. J Oncol Pharm Pract 12:223\u2013236","journal-title":"J Oncol Pharm Pract"},{"key":"1044_CR23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ejrad.2014.01.027","volume":"83","author":"G Keramida","year":"2014","unstructured":"Keramida G, Potts J, Bush J et al (2014) Hepatic steatosis is associated with increased hepatic FDG uptake. Eur J Radiol 83:751\u2013755","journal-title":"Eur J Radiol"},{"key":"1044_CR24","doi-asserted-by":"publisher","first-page":"e0140830","DOI":"10.1371\/journal.pone.0140830","volume":"10","author":"S Kanoun","year":"2015","unstructured":"Kanoun S, Tal I, Berriolo-Riedinger A et al (2015) Influence of software tool and methodological aspects of total metabolic tumor volume calculation on baseline [18F]FDG PET to predict survival in Hodgkin lymphoma. PLoS One 10:e0140830. doi:\n10.1371\/journal.pone.0140830","journal-title":"PLoS One"},{"key":"1044_CR25","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s00259-013-2435-6","volume":"40","author":"E Itti","year":"2013","unstructured":"Itti E, Meignan M, Berriolo-Riedinger A et al (2013) An international confirmatory study of the prognostic value of early PET\/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and DeltaSUVmax. Eur J Nucl Med Mol Imaging 40:1312\u20131320","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-017-1044-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-017-1044-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-017-1044-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T14:42:40Z","timestamp":1589726560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-017-1044-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,31]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1007\/s11307-017-1044-3","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,31]]}}}